Overview Fundamentals API Earnings EOD API Sample Code Pricing

LTR PHARMA FPO (LTP AU) stock market data APIs

A$1.77 0.05(2.9%) as of September 20, 2024
Price chart is built with Anychart

LTR Pharma Limited, a biopharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia. Its lead product candidate is SPONTAN, an intranasal delivery technology, an oral PDE5 inhibitor and vardenafil HCL for the treatment of ED. The company was incorporated in 2020 and is headquartered in Brisbane, Australia.

LTR PHARMA FPO Financial Data Overview

1.715
1.77
-
1.83
1.69
0.235-2.11
96 897 K
0
0
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'LTP',
Type: 'Common Stock',
Name: 'LTR PHARMA FPO',
Exchange: 'AU',
CurrencyCode: 'AUD',
CurrencyName: 'Australian Dollar',
CurrencySymbol: 'A$',
CountryName: 'Australia',
CountryISO: 'AU',
OpenFigi: 'BBG01K4MRM85',
ISIN: 'AU0000305294',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: NULL,
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

LTR PHARMA FPO Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA 0
  • Earnings Per Share
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get LTR PHARMA FPO Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get LTR PHARMA FPO End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com